Journal
NEUROLOGIC CLINICS
Volume 23, Issue 1, Pages 77-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ncl.2004.09.002
Keywords
-
Categories
Ask authors/readers for more resources
Multiple sclerosis (MS) is a chronic neurologic disease affecting approximately I million adults worldwide. Relapses and progression are the two basic clinical phenomena of prototypic MS. Relapses are the clinical expression of acute focal or multifocal inflammatory demyelination disseminated in the central nervous system, whereas progression reflects the occurrence of chronic demyelination, axonal loss, and gliosis. Early in the disease, remission of symptoms likely is the result of remyelination and resolution of inflammation, but after recurrent attacks, remyelination is limited. Inflammatory and noninflammatory factors likely contribute to short- and long-term disability in MS. This review highlights recent advances in experimental neuropathology that have contributed to a better understanding of MS lesion pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available